Results 61 to 70 of about 524,563 (211)

A faded passion? Estes Kefauver and the senate subcommittee on antitrust and monopoly [PDF]

, 2007
In this paper I examine the U.S. Senate subcommittee on antitrust and monopoly (1957-1963), chaired by Tennessee Senator Estes Kefauver. I assess the persistence into the postwar years of the antimonopoly critique of bigness that had animated the ...
Scroop, D.
core  

The Future of Generic Biologics: Should the United States “Follow-On” the European Pathway? [PDF]

, 2008
The United States is embarking on a biotechnology drug revolution. In the last few decades, biotech drugs have saved millions of lives, and the market for these miracle cures continues to grow at an astronomical rate.
Kaldre, Ingrid
core   +1 more source

Drug policy dilemma: ban or tolerance

Социологическая наука и социальная практика, 2016
Due to the significant change in drug situation in Russia and in the world, certain means of social control over distribution of drug consumption are analyzed.
Larisa N. Rybakova
doaj   +1 more source

HB 828: TANF Eligibility; Drug-Related Felonies [PDF]

, 2016
House Bill 828 (HB828) was proposed in 2016 to remove the ban on Temporary Assistance for Needy Families (TANF) for individuals with felony-related drug convictions who are otherwise eligible to receive benefits.
Grace E. Harris Leadership Institute, Virginia Commonwealth University, Hopkins, Greg, Jackson, Carla, Wilson, Rana, Young, Ramunda   +4 more
core   +1 more source

Influence of the legislation on the advertisement of psychoactive medications in Brazil

Brazilian Journal of Psychiatry, 2003
OBJECTIVE: The regulations on the advertisement of medications aim to encourage and promote an improved health care and the rational use of medications. The objective of this paper is to evaluate the influence of three regulations on the advertisement of
Mastroianni Patrícia de Carvalho, Galduróz Jose Carlos Fernandez, Carlini Elisaldo Araújo   +2 more
doaj  

Une « épidémie de drogue » en France dans les années 1960-1980 ?

Histoire, Médecine et Santé
In 1970, drug legislation was strengthened in France in a context where the press and politicians were denouncing a “drug epidemic.” The use of such a metaphor invites us to study both the number of drug addicts in France at that time and the social ...
Alexandre Marchant
doaj   +1 more source

Puerarin-Loaded Proniosomal Gel: Formulation, Characterization, In Vitro Antimelanoma Cytotoxic Potential, and In Ovo Irritation Assessment

Gels
Puerarin is a naturally occurring isoflavone with reported anticancer activity, yet its topical translation is constrained by limited stability and suboptimal dermal delivery. A Puerarin-loaded proniosomal gel was developed as a potential dermal delivery
Sergio Liga, Andra Tămaș, Raluca Vodă, Gerlinde Rusu, Ioan Bîtcan, Vlad Socoliuc, Raluca Pop, Diana Haj Ali, Iasmina-Alexandra Predescu, Cristina Adriana Dehelean, Francisc Péter   +10 more
doaj   +1 more source

Indirect Effects of Pesticide Regulation and the Food Quality Protection Act [PDF]

A driving factor behind pesticide regulation in Canada and the United States is the desire to protect consumers from harmful residues on food. The Food Quality Protection Act (FQPA) was unanimously passed by the U.S.
Cash, Sean B., Sunding, David L., Swoboda, Aaron, Zilberman, David   +3 more
core   +1 more source

Melissa officinalis L. (Lemon Balm): An Integrative Review of Phytochemistry and Evidence from Preclinical Research to Clinical Studies

Plants
Melissa officinalis L. (lemon balm) is a Lamiaceae species widely used in traditional and contemporary herbal practice, yet its reported bioactivities are strongly preparation-dependent, reflecting variability between polyphenol-rich extracts and ...
Ioan-Alexandru Cîmpeanu, Casiana Boru, Cristina Adriana Dehelean, Sergio Liga, Raluca Mioara Cosoroabă, Simona Ardelean, Roxana Popescu, Daliborca Vlad   +7 more
doaj   +1 more source

Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act.

PLoS Medicine
In this Policy Forum piece, Robin Feldman discusses how current legislation contributes to informational deficits around drug patents for biologic drugs in the United States.
Robin Feldman
doaj   +1 more source